← Browse by Condition
Medical Condition

b all

Total Trials
2
Recruiting Now
2
Trial Phases
EARLY_Phase 1, Phase 1

ClinicalMetric tracks all active clinical trials for b all sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — b all Clinical Trials

How many clinical trials are currently recruiting for b all?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for b all, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for b all?
b all research spans Phase 1 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a b all clinical trial?
Eligibility criteria for b all trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Top Sponsors
Memorial Sloan Kettering Cancer Center 1 trial
St. Jude Children's Research Hospital 1 trial

Recruiting Clinical Trials

NCT04512716 EARLY_Phase 1
Recruiting
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Enrollment
12 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT04318678 Phase 1
Recruiting
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Enrollment
108 pts
Location
United States
Sponsor
St. Jude Children's Research H...
View Trial →

Related Conditions

dlbcl (1) dlbcl ci (1) dlbcl unclassifiable (1) dlbcl nos genetic subtypes (1) dlbcl activated b cell type (1) dlbcl germinal center b cell type (1) diffuse large b cell lymphoma (1) hgbl (1) hgbl nos (1) aml mds (1) t all (1) bpdcn (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology